AU2001256148A1 - Subcutaneous administration of coagulation factor vii - Google Patents

Subcutaneous administration of coagulation factor vii

Info

Publication number
AU2001256148A1
AU2001256148A1 AU2001256148A AU5614801A AU2001256148A1 AU 2001256148 A1 AU2001256148 A1 AU 2001256148A1 AU 2001256148 A AU2001256148 A AU 2001256148A AU 5614801 A AU5614801 A AU 5614801A AU 2001256148 A1 AU2001256148 A1 AU 2001256148A1
Authority
AU
Australia
Prior art keywords
factor vii
subcutaneous administration
coagulation factor
coagulation
subcutaneous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001256148A
Inventor
Jens Aas Jansen
Marie Johannessen
Ole Juul Nordfang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27439808&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2001256148(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of AU2001256148A1 publication Critical patent/AU2001256148A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
AU2001256148A 2000-05-03 2001-05-03 Subcutaneous administration of coagulation factor vii Abandoned AU2001256148A1 (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
DKPA200000734 2000-05-03
DKPA200000734 2000-05-03
DKPA200001361 2000-09-13
DKPA200001361 2000-09-13
DKPA200001360 2000-09-13
DKPA200001360 2000-09-13
DKPA200100477 2001-03-22
DKPA200100477 2001-03-22
PCT/DK2001/000302 WO2001082943A2 (en) 2000-05-03 2001-05-03 Subcutaneous administration of coagulation factor vii

Publications (1)

Publication Number Publication Date
AU2001256148A1 true AU2001256148A1 (en) 2001-11-12

Family

ID=27439808

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001256148A Abandoned AU2001256148A1 (en) 2000-05-03 2001-05-03 Subcutaneous administration of coagulation factor vii

Country Status (5)

Country Link
EP (1) EP1280548B1 (en)
JP (1) JP5090605B2 (en)
AU (1) AU2001256148A1 (en)
ES (1) ES2449224T3 (en)
WO (1) WO2001082943A2 (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6905683B2 (en) 2000-05-03 2005-06-14 Novo Nordisk Healthcare A/G Human coagulation factor VII variants
CN101486761A (en) 2000-09-13 2009-07-22 诺沃挪第克健康护理股份公司 Human coagulation factor VII variants
HUP0301246A3 (en) * 2000-09-13 2005-12-28 Novo Nordisk Healthcare Ag Human coagulation factor vii variants
AU2002218029A1 (en) 2000-11-09 2002-05-21 The Scripps Research Institute Modified factor viia
US7052868B2 (en) 2001-09-27 2006-05-30 Novo Nordisk Healthcare A/G Human coagulation factor VII polypeptides
EP1451315B1 (en) * 2001-11-02 2014-05-21 Novo Nordisk Health Care AG Human coagulation factor vii polypeptides
US6960657B2 (en) 2001-11-02 2005-11-01 Novo Nordisk Healthcare A/G Human coagulation factor VII polypeptides
WO2003039581A1 (en) * 2001-11-09 2003-05-15 Novo Nordisk Health Care Ag Pharmaceutical composition comprising factor vii polypeptides and tranexamic acid
EP1458408B1 (en) 2001-12-21 2009-04-15 Novo Nordisk Health Care AG Liquid composition of factor vii polypeptides
AU2003223925A1 (en) * 2002-05-03 2003-11-17 Novo Nordisk A/S Stabilised solid compositions of modified factor vii
CN1671410B (en) * 2002-06-21 2010-05-12 诺和诺德医疗保健公司 Stabilised solid compositions of factor VII polypeptides
US6911323B2 (en) 2002-09-25 2005-06-28 Novo Nordisk Healthcare A/G Human coagulation factor VII polypeptides
AU2004221761B2 (en) * 2003-03-20 2010-01-07 Bayer Healthcare Llc FVII or FVIIa variants
JP4658041B2 (en) 2003-06-25 2011-03-23 ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト Liquid composition of factor VII polypeptide
WO2005002615A1 (en) * 2003-07-01 2005-01-13 Novo Nordisk Health Care Ag Liquid, aqueous pharmaceutical composition of factor vii polypeptides
AU2004264282B2 (en) * 2003-08-14 2010-10-14 Novo Nordisk Health Care Ag Liquid, aqueous pharmaceutical composition of Factor VII polypeptides
CN101870729A (en) 2003-09-09 2010-10-27 诺和诺德医疗保健公司 Coagulation factor vii polypeptides
MXPA06006886A (en) * 2003-12-19 2006-09-04 Novo Nordisk Healthcare Ag Stabilised compositions of factor vii polypeptides.
RU2006138181A (en) 2004-05-04 2008-06-10 Ново Нордиск Хелс Кеа Аг (Ch) O-RELATED Glycoforms of Polypeptides and a Method for Their Production
ES2257225B1 (en) * 2006-02-17 2007-03-16 Grifols, S.A THERAPEUTIC PREPARATION OF FVIIA OF VERY HIGH PURITY AND METHOD FOR OBTAINING IT.
CN101557830B (en) 2006-12-15 2016-06-08 巴克斯特国际公司 There is the factor VIIa-Polysialic acid conjugate of the Half-life in vivo of prolongation
JP5558106B2 (en) * 2007-01-03 2014-07-23 ノボ ノルディスク ヘルス ケア アーゲー Subcutaneous administration of coagulation factor VII-related polypeptide
EP2014299A1 (en) * 2007-07-11 2009-01-14 Novo Nordisk A/S Subcutaneous administration of coagulation factor VII
TWI538916B (en) 2008-04-11 2016-06-21 介控生化科技公司 Factor vii polypeptides that are modified and uses thereof
HUE028056T2 (en) 2009-07-27 2016-11-28 Baxalta GmbH Blood coagulation protein conjugates
US8642737B2 (en) 2010-07-26 2014-02-04 Baxter International Inc. Nucleophilic catalysts for oxime linkage
US8809501B2 (en) 2009-07-27 2014-08-19 Baxter International Inc. Nucleophilic catalysts for oxime linkage
KR101832937B1 (en) 2009-07-27 2018-02-28 박스알타 인코퍼레이티드 Blood coagulation protein conjugates
RU2533619C2 (en) 2009-07-27 2014-11-20 Лайпоксен Текнолоджиз Лимитед Glycopolysialylation of proteins, which are not blood clotting proteins
HUE049352T2 (en) 2010-12-22 2020-09-28 Baxalta GmbH Materials and methods for conjugating a water soluble fatty acid derivative to a protein
MY190257A (en) 2012-04-16 2022-04-11 Cantab Biopharmaceuticals Patents Ltd Optimised subcutaneous therapeutic agents
GB201417589D0 (en) * 2014-10-06 2014-11-19 Cantab Biopharmaceuticals Patents Ltd Pharmaceutical Formulations
CN114728044A (en) 2019-08-15 2022-07-08 介控生化科技公司 Modified factor VII polypeptides for subcutaneous administration and on-demand treatment

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5788965A (en) 1991-02-28 1998-08-04 Novo Nordisk A/S Modified factor VII
GB9122609D0 (en) 1991-10-24 1991-12-04 Brownlee George G Improvements relating to the treatment of haemophilia
IL113010A0 (en) 1994-03-31 1995-10-31 Pharmacia Ab Pharmaceutical formulation comprising factor VIII or factor ix with an activity of at least 200 IU/ml and an enhancer for improved subcutaneous intramuscular or intradermal administration
US6372716B1 (en) 1994-04-26 2002-04-16 Genetics Institute, Inc. Formulations for factor IX
US5925738A (en) * 1995-12-01 1999-07-20 The American National Red Cross Methods of production and use of liquid formulations of plasma proteins
AT408613B (en) * 1998-06-17 2002-01-25 Immuno Ag PHARMACEUTICAL FACTOR VII PREPARATION

Also Published As

Publication number Publication date
JP5090605B2 (en) 2012-12-05
WO2001082943A3 (en) 2002-02-21
WO2001082943A2 (en) 2001-11-08
EP1280548A2 (en) 2003-02-05
ES2449224T3 (en) 2014-03-18
EP1280548B1 (en) 2013-12-11
JP2003531862A (en) 2003-10-28

Similar Documents

Publication Publication Date Title
AU2001256148A1 (en) Subcutaneous administration of coagulation factor vii
AU2001285054A1 (en) Subcutaneous infusion cannula
AU2001241423A1 (en) Needleless syringe
AU2001289640A1 (en) Intracardiac blood pump
AU2001241963A1 (en) Improved medical procedure
AU2002321888A1 (en) Medical needle
AUPQ867900A0 (en) Medical injector system
AU2955200A (en) Cannula
AU2002246515A1 (en) Medicated tattoos
AU2002231039A1 (en) Therapeutic stockings
AU3052700A (en) Medico-surgical discharge cannula
AU2001274548A1 (en) Syringe
AU2001243299A1 (en) Luminescent medical bandage
EP1272240B8 (en) Hypodermic syringe
AU2001243515A1 (en) Combination drug therapy
AU2001276874A1 (en) Continuous preparation of polycarbonate
AU2001286141A1 (en) Perfusion cannula
AU2001264863A1 (en) Preparation of fagopyritols and uses therefor
AU2002240004A1 (en) Infusion cannula
AU2002213420A1 (en) Single-use syringe
AU2001247841A1 (en) Medical procedure
AU2001265280A1 (en) Preparation of 2-hydroxy-5-oxoproline and analogs thereof
AU3064800A (en) The therapeutic use of r-warfarin as anticoagulant
AU2001280079A1 (en) Method of safe infusion
AU6106801A (en) Trans-clitoral administration of therapy